Sun Pharma reportedly plans about ā¹10,000 crore in bonds to partly refinance Organon acquisition loan
The Economic Times, citing Reuters, reports that Sun Pharma plans to sell rupee-denominated bonds to partly refinance a bridge loan used for its Organon acquisition. The bonds are expected to have two-, three- and four-year terms.
TLDR
The Economic Times, citing Reuters, reports that Sun Pharma plans to raise about ā¹10,000 crore through rupee-denominated bonds to partly refinance a bridge loan used for its Organon acquisition. The drugmaker is expected to issue two-, three- and four-year bonds.
Combined views
3.5K
1 Source, first seen 2h ago
likes